DLX2 and hematologic disorder: According to recent reports, deregulation of DLX2 was found in human solid tumors and hematologic malignancies [30, 31, 32], and DLX2 is speculated to be involved in tumor progression via the regulation of metabolic stress-induced necrosis [33].